The Pathogenesis and Therapeutic Option of Encapsulating Peritoneal Sclerosis
Author:
- 1 February 2005
- journal article
- review article
- Published by SAGE Publications in The International Journal of Artificial Organs
- Vol. 28 (2) , 150-155
Abstract
Since the first peritoneal dialysis (PD) patients with encapsulating peritoneal sclerosis (EPS) were reported in 1980, EPS has been considered primarily a fatal complication. The incidence of EPS in PD patients has been reported to be from 0.7% to 7.3%, and the rate appears to be higher in patients receiving long-term treatment. Most data from Japan has shown an overall incidence of 2.5% with an evident negative effect of increasing duration of PD, which also augments mortality. Since EPS occurred after withdrawal from PD in more than half of the patients, strict monitoring is necessary when a long-term PD patient is withdrawn from PD. Maintaining patients on standard PD for more than 8 years using conventional solutions is associated with a substantial risk for development of EPS. Appropriate treatment according to the disease stage is most important in EPS treatment. Therefore, when examining a PD patient complaining of gastrointestinal symptoms, the possibility of EPS has to be kept in mind. Basic therapeutic tactics for EPS include an appropriate use of steroids. If the state of bowel obstruction persists, laparotomy and enterolysis should be performed to obtain complete cure. It is now recognized that EPS is not a fatal complication of PD.Keywords
This publication has 28 references indexed in Scilit:
- Encapsulating peritoneal sclerosis in Japan: A prospective, controlled, multicenter studyAmerican Journal of Kidney Diseases, 2004
- Encapsulating Peritoneal Sclerosis: Definition, Etiology, Diagnosis, and TreatmentPeritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis, 2000
- Sclerosing peritonitis: the experience in AustraliaNephrology Dialysis Transplantation, 1998
- Sclerosing encapsulating peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: A report of the Japanese Sclerosing Encapsulating Peritonitis Study GroupAmerican Journal of Kidney Diseases, 1996
- Histologic changes induced by intraperitoneal chemotherapy with 5-fluorouracil and mitomycin c in patients with peritoneal carcinomatosis from cystadenocarcinoma of the colon or appendixCancer, 1990
- Preliminary Report on a Cooperative International Study on Sclerosing Encapsulating Peritonitis1987
- Sclerosing Encapsulating Peritonitis in Rats: an Experimental Study with Intraperitoneal Antiseptics11987
- Renal Effects of FenoprofenAnnals of Internal Medicine, 1980
- Peritoneal Tuberculosis with Ureteric Obstruction, Mimicking Retroperitoneal FibrosisBritish Journal of Urology, 1976
- SCLEROSING PERITONITIS, AN UNUSUAL REACTION TO A β-ADRENERGIC-BLOCKING DRUG (PRACTOLOL)The Lancet, 1974